These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2208701)

  • 21. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Standardization of the methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia].
    Grafnetter D; Feruglio GA; Vanuzzo D
    G Ital Cardiol; 1996 Mar; 26(3):287-97. PubMed ID: 8690184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
    Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
    Tornvall P; Karpe F; Carlson LA; Hamsten A
    Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
    Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
    J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point: status of lipid and lipoprotein standardization.
    McNamara JR; Leary ET; Ceriotti F; Boersma-Cobbaert CM; Cole TG; Hassemer DJ; Nakamura M; Packard CJ; Seccombe DW; Kimberly MM; Myers GL; Cooper GR
    Clin Chem; 1997 Aug; 43(8 Pt 1):1306-10. PubMed ID: 9267305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
    Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
    Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between the triglycerides standardization of routine methods used in Japan and the chromotropic acid reference measurement procedure used by the CDC Lipid Standardization Programme.
    Nakamura M; Iso H; Kitamura A; Imano H; Noda H; Kiyama M; Sato S; Yamagishi K; Nishimura K; Nakai M; Vesper HW; Teramoto T; Miyamoto Y
    Ann Clin Biochem; 2016 Nov; 53(6):632-639. PubMed ID: 26680645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
    Brewer HB
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical performance of a direct assay for LDL-cholesterol: a comparative assessment versus Friedewald's formula.
    Türkalp I; Cil Z; Ozkazanç D
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):13-7. PubMed ID: 15755695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The triglyceride connection in atherosclerosis.
    Geurian K; Pinson JB; Weart CW
    Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.
    Bookstein L; Gidding SS; Donovan M; Smith FA
    Arch Intern Med; 1990 Aug; 150(8):1653-7. PubMed ID: 2383160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extent of coronary sclerosis in relation to lipoprotein lipase activity and plasma triglyceride levels].
    Breier C; Mühlberger V; Herold M; Drexel H; Lisch HJ; Knapp E; Braunsteiner H
    Schweiz Med Wochenschr; 1985 Sep; 115(37):1263-7. PubMed ID: 4059897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma triglyceride measurement. A comparison of four commercial methods.
    Asmal AC; Lockett CJ; Deppe WM; Leary WP
    S Afr Med J; 1975 Jul; 49(28):1133-4. PubMed ID: 1154166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.